oncologic nursing part 2

Upload: maria-erika

Post on 30-May-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Oncologic Nursing Part 2

    1/111

    Cancer Detection

    and Testing Detecting cancers early is an importantstep in preventing significant health

    problems. Give the accurate manage for the present

    illness(stage) of patient

    To prevent further complication

  • 8/14/2019 Oncologic Nursing Part 2

    2/111

    Outcomes in

    Detecting Cancer True positive- test indicates that a patient has a disease

    that the patient does indeed have

    False positive

    - if the test indicates that a patient has adisease when she does not

  • 8/14/2019 Oncologic Nursing Part 2

    3/111

    Outcomes in

    Detecting Cancer True negative - test indicates the patient is disease-

    free, and this is indeed the case

    False negative

    - test indicates the patient is healthy whenin fact the patient has the disease

  • 8/14/2019 Oncologic Nursing Part 2

    4/111

    Specificity of

    Medical Tests Sensitivity refers to how accurately a testidentifies people who have the disease.

    Specificity refers to how accurately a testidentifies people who do not have the disease

    The best medical tests have high sensitivity

    and high specificity.

  • 8/14/2019 Oncologic Nursing Part 2

    5/111

    SENSITIVITY It refers to the proportion of the times that

    a test yields true positives.

    The closer the sensitivity is to 100%, themore likely a positive result actually meansthat the patient has a disease.

    The sensitivity of a medical test is a measureof how well the test identifies people whohave a particular disease.

  • 8/14/2019 Oncologic Nursing Part 2

    6/111

    SPECIFICITY It refers to the proportion of the time

    that a test yields true negatives.

    The closer the specificity is to 100%, themore likely a negative result means thatthe patient is truly disease-free.

    The specificity of a medical test is ameasure of how well the test identifiespeople who do not have a particular disease

  • 8/14/2019 Oncologic Nursing Part 2

    7/111

    Importance: samples may show cancer cells,

    proteins or other substances made bythe cancer

    idea of how well your organs arefunctioning and if they've beenaffected by cancer

    enera

    Detection

  • 8/14/2019 Oncologic Nursing Part 2

    8/111

    Non - Invasive InvasiveTechniques

    Analysis of Biopsy

    Complete Blood

    Count (CBC)UltrasoundMRIPET ScanCT Scan

    Fine Needle

    Aspiration

    Core Needle Biopsy

    Immunohistochemistry

    (IHC)

    Fluorescent In SituHybridization (FISH)

    enera

    Detection

  • 8/14/2019 Oncologic Nursing Part 2

    9/111

    A. Complete blood count (CBC) It provides information about the number, parts,

    shape, and structure of the different cell types

    found in blood. 3 Main Types of Blood cells: WBC RBC Platelets

    Blood cancers may be detected using this test iftoo many or too few of a type of blood cell or

    abnormal cells are found. eg., Leukemias

    and Diagnostic

    Techniques

  • 8/14/2019 Oncologic Nursing Part 2

    10/111

    Leukocyte ( WBC)

    Are major players in the immune system and

    help defend against infection and disease. WBC can be divided into two main groups:

    Phagocytes Lymphocytes

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    11/111

    Leukocyte ( WBC) Phagocytes-

    Are cells that are able to consume and breakdown foreign material, invading microbes andbroken down cells/cell parts.

    They get their name from the Greek'phagein', to eat.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    12/111

    Leukocyte ( WBC) Lymphocytes- These are recognition cells responsible for

    initiating the specific immune response of theimmune system.

    Three Major Types of Lymphocytes

    B cells T cells natural killer cells (NK cells)

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    13/111

    T- Cells Formed by the pluripotent stem cells in

    the bone marrow, T-cells mature in thethymus (a small organ located in the upperportion of the chest).

    Two Subtypes of T cells; cytotoxic T cells (CD8 cells) helper T cells (CD4 cells).

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    14/111

    T- Cells Cytotoxic T cells (CD8 cells)

    bind specifically to targetcells; virally infected cells,

    cancer cells, or any foreign cells. After binding,cytotoxic T cells directly destroy the target cell.

    Helper T cells (CD4 cells)release special chemicals that help activate other cells

    of the immune response, including; B cells, cytotoxic Tcells, other helper T cells, NK cells, and macrophages.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    15/111

    B- Cells These cells are produced from

    the pluripotent stem cells in

    the bone marrow and stay inthe marrow to mature. B cells bind to their specific

    antigens, become activated

    'plasma' cells and secretelarge amounts antibodies.

    Natural killercells (NK cells)

    It bind to virallyinfected cells andcancer cells anddirectly kill them.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    16/111

    Granulocytes granules contain

    chemicals and proteins

    (from cells)

    controlinflammatory andimmune functions.

    Granulocytes are alsocapable of engulfingand destroying foreignmatter

    NeutrophilsAre usually the first

    cells to arrive at the

    scene of infection orinflammation

    They engulf anddestroy foreignmatter and then die,forming pus

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    17/111

    Eosinophils

    known to play a

    role in parasiticinfections andallergic reactions

    Basophils

    These cells are

    stimulated byother immune cellsand play a role in

    systemic allergicreactions.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    18/111

    Granulocytes lack the granules

    of granulocytes

    capable ofengulfing and

    destroying foreignmatter.

    Monocytes/Macrophages

    These cells are the largesttype of white blood cell.

    The second cells on thescene of a problem.

    They engulf and processforeign matter so thatlymphocytes can recognize itand mount a specificdefense.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    19/111

    CBC: Red Blood Cells (RBC)

    Red blood cells (also called erythrocytes)

    pick up oxygen in the lungs and deliver itto the rest of the cells in the body.

    2 Subtypes of RBC

    HemoglobinHematocrit

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    20/111

    NON-INVASIVEA. Complete blood count (CBC)

    Hemoglobin

    Each red blood cell carries around 300

    million molecules of a protein calledhemoglobin. Hemoglobin is what actually grabs and

    carries oxygen. Each molecule of hemoglobin can carry 4molecules of oxygen

  • 8/14/2019 Oncologic Nursing Part 2

    21/111

    Hematocrit The hematocrit is the proportion of red blood cells

    to an entire sample of blood (red blood cells /

    blood). It may also be called packed cell volume (PCV) and it

    is normally represented as a percentage.

    For example: a hematocrit of 30% means there are30 milliliters of red blood cells in 100 milliliters ofblood.

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    22/111

    Reticulocyte Count

    Is the percentage of immature red blood

    cells (reticulocytes) in the total red bloodcell count (reticulocytes / red blood cells).

    1-2% of the total RBC count

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    23/111

    Red Blood Cell Indices The RBC indices evaluate the structure of

    red blood cells and hemoglobin. They include:

    mean corpuscular volume (MCV)

    mean corpuscular hemoglobin (MCH) mean corpuscle hemoglobin concentration

    (MCHC).

    NON-INVASIVEA. Complete blood count (CBC)

  • 8/14/2019 Oncologic Nursing Part 2

    24/111

    MCV describes the sizeor volume of RBC's

    Classificatioon;

    microcytic (small), normocytic (normal) macrocytic (large)

    MCH describes theaverage weight of thehemoglobin in the RBC's.A small RBC will have asmaller MCH.

    MCHC describes theaverage concentration ofhemoglobin in the RBC's

    Classification: hypochromic (lowconcentration, pale color),

    normochromic (normalconcentration, normal color)

    hyperchromic (increasedconcentration, bright redcolor).

    NON-INVASIVERed Blood Cell Indices

  • 8/14/2019 Oncologic Nursing Part 2

    25/111

    Urine cytology- reveal cancer cells thatcould come from the bladder, ureters orkidneys

    Blood protein testing- examine variousproteins in your blood (electrophoresis)can aid in detecting certain abnormalimmune system proteins

    and Laboratory

    Techniques

  • 8/14/2019 Oncologic Nursing Part 2

    26/111

    Tumor marker tests- chemicals madeby tumor cells that can be detected in yourblood

    prostate-specific antigen (PSA)- for prostatecancer cancer antigen 125 (CA 125)- for ovarian

    cancer

    Calcitonin- for medullary thyroid cancer alpha-fetoprotein (AFP)- for liver cancer human chorionic gonadotropin (HCG)- for germ

    cell tumors, such as testicular cancer and

    ovarian cancer

    and Laboratory

    Techniques

  • 8/14/2019 Oncologic Nursing Part 2

    27/111

    General Detection (DIAGNOSTIC TECHNIQUES)

    ULTRASOUND

  • 8/14/2019 Oncologic Nursing Part 2

    28/111

    ULTRASOUND(UTZ)

    is an ultrasound-baseddiagnostic imagingtechnique used to

    visualize subcutaneousbody structures

    A computer program is

    used to analyze theechoes of sound wavessent into the bodyand generates anima e on screen.

    ULTRASOUND

    http://en.wikipedia.org/wiki/Ultrasoundhttp://en.wikipedia.org/wiki/Medical_imaginghttp://en.wikipedia.org/wiki/Medical_imaginghttp://en.wikipedia.org/wiki/Ultrasound
  • 8/14/2019 Oncologic Nursing Part 2

    29/111

    Purpose of UTZ

    Are good exams to gain important

    information about a suspicious mass

    It can be used to help guide a needle

    during a biopsy.

    ULTRASOUND(UTZ)

  • 8/14/2019 Oncologic Nursing Part 2

    30/111

    Can detect lesions in women with dense breasts

    when mammograms cannot.

    Less expensive than a mammogram.

    Present the difference between a cyst and a solidmass without using a needle to draw out fluid (non-

    invasive).

    Never exposed to radiation detect blood flow through vessels

    no known harmful effects to humans.

    (UTZ)

    ADVANTAGES

  • 8/14/2019 Oncologic Nursing Part 2

    31/111

    (UTZ)

    DISADVANTAGES Sometimes it is unable to determinewhether or not a mass is malignant, and abiopsy will be recommended.

    Many cancers cannot be detected via anultrasound.

    Calcifications that are visible onmammograms are not visible on ultrasoundscans

  • 8/14/2019 Oncologic Nursing Part 2

    32/111

    RESONANCE

    IMAGING(MRI)Also called as nuclearmagnetic resonanceimaging (NMRI)

    Can locate and describethe gross extent of amass or tumor but cannotdifferentiate betweenbenign and malignant

    http://en.wikipedia.org/wiki/2D-FT_NMRI_and_Spectroscopyhttp://en.wikipedia.org/wiki/2D-FT_NMRI_and_Spectroscopy
  • 8/14/2019 Oncologic Nursing Part 2

    33/111

    When contrast agent is not used an MRIcan show: When contrast agent is used MRI canshow:

    contrast agent is not used an MRI can

    show:The shape, size, appearance, and locationof organs, bones, and jointsThe presence of abnormal growthsSigns of inflammation or infection

    size and location of benign or malignant

    growthsenlarged lymph nodeschanges in blood flowextracellular volume

    RESONANCE

    IMAGING(MRI)

  • 8/14/2019 Oncologic Nursing Part 2

    34/111

    Tomography

    (PET) Is an imaging technique that usesradioactive molecules to create a dynamicimage of internal tissues and organs.

    It produce images that reveal the activityof living tissue.

    PET scans use radioactively labeled tracers(radiotracers) that are injected into thebloodstream

    PET SCAN

  • 8/14/2019 Oncologic Nursing Part 2

    35/111

    Drink plenty of water, but do not eat or drink anything(except water) for 6 hours before your exam

    Take your medications normally and drink them with

    ample water Make sure you arrive at the imaging center on time, the

    compound used for the scan breaks down rapidly and ifyou are late, the images may not be as good

    Wear loose fitting clothing

    Do not wear any jewelry; watches, chains, rings,piercings, etc

    PET SCANPreparation:

  • 8/14/2019 Oncologic Nursing Part 2

    36/111

    Tomography

    CTs Scan uses special

    x-rayequipment toobtain cross-

    sectionalpictures of thebody

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=x-ray&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=x-ray&version=Patient&language=English
  • 8/14/2019 Oncologic Nursing Part 2

    37/111

    Use In Cancer to:To detect or confirm the presence of a tumor;To provide information about the size and

    location of the tumor and whether it has spread;To guide a biopsy (the removal of cells or tissues

    for examination under a microscope);

    To help plan radiation therapy or surgery; andTo determine whether the cancer is responding

    to treatment.

    Tomography

    CTs Scan

    i

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=biopsy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=cell&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=radiation%20therapy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=surgery&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=surgery&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=radiation%20therapy&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=cell&version=Patient&language=Englishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?term=biopsy&version=Patient&language=English
  • 8/14/2019 Oncologic Nursing Part 2

    38/111

    Biopsy

    - is the removal oftissue from a

    living subject todetermine thepresence orextent of a

    disease- Visualization of

    change cell

    microscopically

    CYTOLOGY SPECIMENSpecimen can be obtain

    from tumors that tend to

    shed cells from their

    BIOPSY

  • 8/14/2019 Oncologic Nursing Part 2

    39/111

    BIOPSY

    NEEDLE BIOPSY Incision Biopsy

    Only part of tumoris removed

    Cell tissue only

    NEEDLE BIOPSY Excision Biopsy

    Entire tumor issurgically removed forexamination

    Used for small tumors(2-3cm)

    Serve as treatment iftissue margin containno tumor cells

    Biopsy

  • 8/14/2019 Oncologic Nursing Part 2

    40/111

    BiopsyInvasive Techniques

    Fine needleaspiration (FNA) uses a small needle

    to collect smallsamples of a lesion.

    Core needle biopsy(CNAB) uses a larger

    needle to collectsamples of a lesion

    Biopsy

  • 8/14/2019 Oncologic Nursing Part 2

    41/111

    Fine needle aspiration(FNA)

    ADVANTAGES: diagnose benign lesions Inexpensive, quick, readily

    available, and very safe

    DISADVANTAGES: No ability to differentiate

    between in situ andinvasive breast cance

    Core needle biopsy (CNAB) ADVANTAGES:

    Strong ability to specificallydiagnose benign lesions.

    Some ability to differentiatebetween in situand invasivebreast cancer.

    DISADVANTAGES:

    More invasive, timeconsuming, expensive

    BiopsyInvasive Techniques

    Analysis of Biopsy

  • 8/14/2019 Oncologic Nursing Part 2

    42/111

    Analysis of BiopsySamples

    mmunohistochemistry (IHC) measures protein expression

    using specially labeled

    antibodies. example: Three proteins ofparticular interest in breastcancer are HER2, the

    estrogen receptor (ER) andthe progesterone receptor(PR).

    Fluorescence in SituHybridization (FISH)

    measures genetic changes (i.e.amplification) using

    fluorescently labeled DNAprobes.

    Is a technique that measuresgene amplification andchromosomal abnormalities usingfluorescently labeled DNAprobes.

    Cancer Specific

  • 8/14/2019 Oncologic Nursing Part 2

    43/111

    Cancer SpecificTechniques

    Mammography

    uses low dose x-

    ray to create animage of abreast.

  • 8/14/2019 Oncologic Nursing Part 2

    44/111

    Techniques

    Direct Visualization Direct VisualizationSigmoidoscopy uses a small tube containing

    viewing equipment to view the colon.Virtual Colonoscopy uses an MRI or CT scan to

    create an image of the inside of the colon. Bronchoscopy Endoscopy

    Cystoscopy

    Exploratory Surgery

    Cancer Specific

  • 8/14/2019 Oncologic Nursing Part 2

    45/111

    Cancer SpecificTechniques

    Pap smears use a sample of cells from thecervix to detect cervical cancer. Papsmears may also detect ovarian anduterine cancers that have migrated to thecervix.

    Prostate specific antigen (PSA) testmeasures levels of a glycoprotein in theblood. Elevated levels of PSA areassociated with prostate cancer

    Sentinel Lymph

  • 8/14/2019 Oncologic Nursing Part 2

    46/111

    Sentinel LymphNode Biopsy (SLN)

    Use to detect metastasis

    the hypothetical first lymph node or

    group of nodes reached by metastasizingcancer cells from a tumor

    used in the staging of certain types of

    cancer to see if they have spread to anylymph node

    http://en.wikipedia.org/wiki/Lymph_nodehttp://en.wikipedia.org/wiki/Lymph_node
  • 8/14/2019 Oncologic Nursing Part 2

    47/111

    Staging

    GRADING

    Evaluation of degree ofdifferentiation of cancercells

    Grade 1- the least

    malignantTo Grade 4- the most

    malignant Grade 1- the most

    differentiatedTo

    Grade 4- the leastdifferentiated

    STAGING

    The process of describing thelocal extent of the disease orthe spread of cancer fromthe original site

    Essential in determining thechoice of therapy andassessing prognosis

    Based on information aboutthe tumor size and location inthe body, and whether or notit has spread to other areasof the body

    TNM Staging

  • 8/14/2019 Oncologic Nursing Part 2

    48/111

    TNM StagingSystem

    Measure tumors in threeways:

    Primary Tumor (T)

    Node (N)

    Metastasize (M)

    TNM Stag ng

  • 8/14/2019 Oncologic Nursing Part 2

    49/111

    TNM Stag ngSystem

    Tumor

    T0- no evidence of primary tumor TIS- carcinoma in situ T1-T4- ascending degrees of tumor size and

    involvement

    ag ng

  • 8/14/2019 Oncologic Nursing Part 2

    50/111

    Nodes

    N0- no evidence of disease in lymph nodes

    N1a, N2b- disease found in regional lymphnodes, metastasis not suspected N1a, N2b, N3 - disease found in regional

    lymph nodes, metastasis suspected

    ag ngSystem

    TNM Staging

  • 8/14/2019 Oncologic Nursing Part 2

    51/111

    Metastasis

    M0- no evidence of distant metastasis M1, M2, M3- Ascending degrees of

    metastasis involvement, including

    distant nodes

    TNM StagingSystem

    ag ng

  • 8/14/2019 Oncologic Nursing Part 2

    52/111

    Once the T, N, and M are determined, a Stageof I, II, III, or IV is assigned

    Stage I - (T1,N0,M0) - Early StageStage II - (T2,N1,M0) - Local SpreadStage III - ( T3,N2,M0) Extensive

    spread but no metastasis

    Stage IV (T4,N3,M+) Advancedstage, with distantmetastasis

    ag ngSystem

  • 8/14/2019 Oncologic Nursing Part 2

    53/111

    Prevention and

    Control1. Primary Prevention Focuses on eliminating the

    conditions that cause cancer todevelop Pre-cancerous stage

  • 8/14/2019 Oncologic Nursing Part 2

    54/111

    2. Secondary Prevention Refers to early detection coupled

    with effective therapy Cancer maybe curable in early

    stage.

    Prevention and

    Control

  • 8/14/2019 Oncologic Nursing Part 2

    55/111

    3. Tertiary Prevention Refers to the prevention of cancer

    recurrence, symptoms andcomplication Involves Supportive Care,

    Rehabilitation and pain relief

    Prevention and

    Control

    C

  • 8/14/2019 Oncologic Nursing Part 2

    56/111

    Cancer

    TreatmentObjectives:

    Aims to prevent cancer fromspreading locally or recurring/

    relapsing at sites distant fromthe original location.

    T

  • 8/14/2019 Oncologic Nursing Part 2

    57/111

    Treatments Surgery Radiation Therapy Hormonal Therapy Targeted Therapy Antibodies Cancer Vaccines Complimentary and Alternative Medicines Chemotherapy

    TREATMENT

  • 8/14/2019 Oncologic Nursing Part 2

    58/111

    TREATMENTMODALITIES

    A. Loco-Regional Treatment

    1. Surgery

    2.

    Radiation Therapy3. Transplant

    B. Systemic Treatment

    1. Cytotoxic Chemotherapy2. Hormonal Therapy

    SURGERY

  • 8/14/2019 Oncologic Nursing Part 2

    59/111

    SURGERY The first line of treatment for many solid

    tumors. M single cancer cell is invisible to the naked eye

    but can regrow into a new tumor, a processcalled recurrence

    A local treatment used to remove visible tumorsor the entire organ

    Purposes: Diagnose Cure Control Pallative

    SURGERY

  • 8/14/2019 Oncologic Nursing Part 2

    60/111

    SURGERY Local Excision- simple surgery with small

    margin of normal tissue surroundingtumor.

    En bloc Dissection- removal of tumor,tissues, and any contiguous structures.

    Surgery on Cancer

  • 8/14/2019 Oncologic Nursing Part 2

    61/111

    Surgery on Cancerin Situ

    Electrosurgery- application of electricalcurrent to cancerous cells

    Cryosurgery- deep freezing with liquidnitrogen

    Chemosurgery- applied chemotherapeutic

    agents layer by layer with surgicalincision.

    Co2 laser- use of laser for laser excision.

    RADIATION

  • 8/14/2019 Oncologic Nursing Part 2

    62/111

    RADIATIONTHERAPY

    The use of high-energy ionizing rays totreat a variety of cancers

    Destroys the cells ability to reproduce by

    damaging the cells DNA Rapidly dividing cells are more vulnerable

    to radiation than slower dividing cells

    It can be used alone or in conjunction withother treatments (e.g. chemotherapy andsurgery) to cure or stabilize cancer.

    RADIATION

  • 8/14/2019 Oncologic Nursing Part 2

    63/111

    Objectives: This treatment seeks to relieve symptoms of the

    cancer and to prolong survival, making life more

    comfortable. Types of Radiation Therapy

    External Radiation Therapy

    Internal Radiation Therapy Photon Radiation

    RADIATIONTHERAPY

    Types of Radiation

  • 8/14/2019 Oncologic Nursing Part 2

    64/111

    Types of RadiationTherapy

    1. External RadiationTherapy Administered by

    high energy X-ray machines(e.g. Betatronand Linear

    Accelerator) ormachinescontainingradiosotope

  • 8/14/2019 Oncologic Nursing Part 2

    65/111

    Nursing Care Marks must not remove Keep the skin dry

    Talcum and Lotions are contraindicated Avoid strong sunlight, extremestemperature, constricting clothes.

    No Eating (NPO) Patient is not the SOURCE of Radiation

    after the procedure.

    Types of Radiation

  • 8/14/2019 Oncologic Nursing Part 2

    66/111

    Internal Radiation Therapy Involves the placement of specially

    prepared radioisotopes directlyinto near the tumor itself or intothe systemic circulation

    Also called brachytherapy

    Types of RadiationTherapy

    Types of Internal

  • 8/14/2019 Oncologic Nursing Part 2

    67/111

    Types of InternalRadiation Therapy

    Sealed Source RT(Brachytherapy)Un Sealed- Source RT

    S l d S RT

  • 8/14/2019 Oncologic Nursing Part 2

    68/111

    Sealed- Source RT

    Sealed radiation source isplaced in a cavity or adjacent

    to cancer.

    Ex: Radium, Iridium, Cesium

    S l d S RT

  • 8/14/2019 Oncologic Nursing Part 2

    69/111

    INTRACAVITARY TherapyRadioisotope is placed into an applicator, then

    placed into the body cavity for a carefully

    calculated time (usually 24 72 H)

    Ex: Radioisotopes: Celsium 137

    Radium 226

    Sealed- Source RT

    Sealed- Source

  • 8/14/2019 Oncologic Nursing Part 2

    70/111

    INTERSTITIAL THERAPY Radioisotope of choice is placed into needles,

    beads, seeds, ribbons or catheters and then

    implanted directly into the tumor. Implants may be left in the tumor temporarily

    or permanently.

    Ex: Iridium 192, Iodine 125, Celsium 137, Gold198, Radon 222

    Sealed SourceRT

    UNSEALED SOURCE

  • 8/14/2019 Oncologic Nursing Part 2

    71/111

    UNSEALED SOURCERT

    Used in Systemic therapy. Source of Radiation is given orally,

    intravenously. PO Administration: Low dose: Graves

    Disease 131I High Dose: Thyroid Ca

    IV Administration: 32p TreatsPolycythemia Vera

    Other Types of

  • 8/14/2019 Oncologic Nursing Part 2

    72/111

    It uses high energy rayscomposed of particles of energy

    called photons.

    Gamma rays: are produced by

    the breakdown of radioactive

    isotopes of elements such as

    Cobalt-60 and radium

    X-rays: originate from machinesthat excite electrons using

    cathode ray tubes or linear

    accelerators.

    Other Types ofRadiation Therapy

    Nursing Care Highlight

  • 8/14/2019 Oncologic Nursing Part 2

    73/111

    Care of the Client with Sealed Implants of

    Radioactive Sources

    Assign the client to a privateroom, with private bath.

    Place Caution: RadioactiveMaterial sign on the door of

    the clients room. Pregnant nurses should not

    care for these clients; do notallow children younger than 16

    and pregnant women to visit.

    Limit each visitor to hour per day

    Never touch the

    radioactive materialwith bare hands Save all dressings

    and bed linens until

    after theradioactive sourceis removed.

    RADIATION

  • 8/14/2019 Oncologic Nursing Part 2

    74/111

    RADIATIONSAFETY

    Three factors which determine thetotal exposure one receives in a givenradiation field are:

    1. Time of exposure.

    2. Distance from Source.

    3. Amount of shielding present.

    TIME

  • 8/14/2019 Oncologic Nursing Part 2

    75/111

    TIME

    The less time

    you spend near asource, the lessradiation you will

    receive

    The Shortest Possible Time

    DISTANCE

  • 8/14/2019 Oncologic Nursing Part 2

    76/111

    DISTANCE As far as possible

    ( can spend moretime at a distanceof 20 feet)

    The farther you get

    from a source, theless radiation youwill receive.

    SHIELDS

  • 8/14/2019 Oncologic Nursing Part 2

    77/111

    SHIELDS

    The more

    shielding youhave, the lessradiation you will

    receive.

    Protective Lead Apron

    Advantages of

  • 8/14/2019 Oncologic Nursing Part 2

    78/111

    Advantages ofRadiotherapy

    Destroys quickly dividing cells at the marginsof tumors. Surgery may miss these cellsleading to recurrence of disease.

    Can successfully eradicate growth withoutpermanently damaging the adjacent normal

    In conjunction with other treatments, maycure tumors that are not responsive to anysingle agent.

    S S C

  • 8/14/2019 Oncologic Nursing Part 2

    79/111

    II. SYSTEMIC TREATMENT

    HORMONAL THERAPY

    Fights cancer byaltering the

    amounts ofhormones in thebody.

    BIOLOGIC TREATMENTS

    Referred to by many termsincluding: Immunologictherapy, Immunotherapy,

    biotherapy. (Interferon,Interleukin)

    Often used to help restorethe functioning of the

    immune system. Stimulates the disease-

    fighting ability of the body.

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2

    80/111

    CHEMOTHERAPY Chemo, refers to a wide

    range of drugs used totreat cancer

    work by damaging the

    dividing cancer cells andpreventing their furtherreproduction

    Death of the normal cells

    produces some of thecommon side-effects ofchemotherapy.

    PRINCIPLE OFCHEMOTHERAPY

    Timing of dose around thecell cycle and in relation

    to other drugs is critical Combination therapy is

    more effective Effectiveness of the drug

    relies on the number ofcells in division

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2

    81/111

    The use of powerful drugs to:

    Kill Cancer CellsControl their GrowthRelieve Pain Symptoms

    CHEMOTHERAPY

    Types of

  • 8/14/2019 Oncologic Nursing Part 2

    82/111

    ypes oChemotherapy

    Types of

  • 8/14/2019 Oncologic Nursing Part 2

    83/111

    Types ofChemotherapy

    1. Primary ChemotherapyThe use chemotherapy alone for the cure ofa specific tumor.

    2. Adjuvant ChemotherapyThe use of chemotherapy after primary,loco regional treatment, with the intent of

    decreasing the relapse rate and improvingsurvival.

    Types of

  • 8/14/2019 Oncologic Nursing Part 2

    84/111

    Types ofChemotherapy

    3. Neo- adjuvant ChemotherapyThe use of chemotherapy before loco- regionaltreatment with the intent of decreasing tumor

    size enhancing chances for resectability andpreservation of normal structures.

    4. Concurrent Chemotherapy

    The use of chemotherapy combined withradiotherapy in order to increase local responseand control systemic spread.

    ypes o

  • 8/14/2019 Oncologic Nursing Part 2

    85/111

    ypes oChemotherapy

    5. Palliative Chemotherapy

    The use of chemotherapy in advancedmalignancies, the intent of which is notcure but control of the disease and tumorrelated symptoms.

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2

    86/111

    Types Antineoplastic Agents- drugs that inhibit and combat the

    development of neoplasms Classes:

    Antimetabolites Genotoxic Drugs

    Alkylating agents: Intercalating agents

    Enzyme inhibitors

    CHEMOTHERAPYDRUGS

    CHEMOTHERAPY

  • 8/14/2019 Oncologic Nursing Part 2

    87/111

    Types

    Spindle Inhibitors

    Additional Chemotherapy Agents

    CHEMOTHERAPY

    ANTIMETABOLITE

  • 8/14/2019 Oncologic Nursing Part 2

    88/111

    ANTIMETABOLITES

    Drugs that interfere with the formation ofkey biomolecules within the cell.

    work by blocking the activity of enzymes These drugs often prevent the normal

    replication of DNA , nucleic acids andtherefore cell division.

    Other antimetabolites may interfere withthe creation of RNA or other cellularprocesses

    ANTIMETABOLITE

    http://www.cancerquest.org/dictionary.cfm?lookup_id=DNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=RNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=RNA&lang=englishhttp://www.cancerquest.org/dictionary.cfm?lookup_id=DNA&lang=english
  • 8/14/2019 Oncologic Nursing Part 2

    89/111

    Classes:

    Folate Antagonists- known as antifolates

    inhibit dihydrofolate reductase (DHFR), an enzyme

    involved in the formation of nucleotides. When thisenzyme is blocked, nucleotides are not formed,disrupting DNA replication and cell division

    Ex. Methotrexate (Wellcovorin):

    ADVERSE EFFECTBone marrow depression stomatitis

    ANTIMETABOLITES

    ANTIMETABOLITE

    http://www.cancerquest.org/index.cfm?page=430http://www.cancerquest.org/index.cfm?page=430
  • 8/14/2019 Oncologic Nursing Part 2

    90/111

    Purine Antagonists purines (adenine and guanine) are chemicals used to

    build the nucleotides of DNA and RNA

    inhibiting DNA synthesis in two different ways They can inhibit the production of the purine

    containing nucleotides, adenine and guanine

    They may be incorporated into the DNA moleculeduring DNA synthesis

    Ex. 6-Mercaptopurine, Dacarbazine, Fludarabine

    ANTIMETABOLITES

    ANTIMETABOLITE

    http://www.cancerquest.org/index.cfm?page=435http://www.cancerquest.org/index.cfm?page=435
  • 8/14/2019 Oncologic Nursing Part 2

    91/111

    Pyrimidine Antagonists act to block the synthesis of pyrimidine containing

    nucleotides (C and T in DNA; C and U in RNA). The drugs used to block the construction of these

    nucleotide have structures that are similar to thenatural compound.

    By acting as 'decoys', these drugs can prevent the

    production of the finished nucleotides. They may exerttheir effects at different steps in that pathway andmay directly inhibit crucial enzymes.

    Ex. 5-fluorouracil; Arabinosylcytosine

    OS

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2

    92/111

    Drugs that damage DNA. By causing DNAdamage, these agents interfere with DNAreplication, and cell division

    3 Treatments: Alkylating Agents Intercalating Agents Enzyme Inhibitors

    eno ox c

    Drugs

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2

    93/111

    Alkylating agents:

    The first class of chemotherapy agentsused. These drugs modify the bases ofDNA, interfering with DNA replicationand transcription and leading to mutations

    eno ox c

    Drugs

    eno ox c

  • 8/14/2019 Oncologic Nursing Part 2

    94/111

    Intercalating agents These drugs wedge themselves into the spaces

    between the nucleotides in the DNA double

    helix. They interfere with transcription,replication and induce mutations.

    Enzyme inhibitors

    These drugs inhibit key enzymes, such astopoisomerases, involved in DNA replicationinducing DNA damage.

    eno ox c

    Drugs

    p n e

  • 8/14/2019 Oncologic Nursing Part 2

    95/111

    p n eInhibitors

    These agents prevent proper cell divisionby interfering with the cytoskeletalcomponents that enable one cell to divide

    into two. Vinca Alkaloids

    Paclitaxel (Taxol)Docetaxel (Taxotere)Ixabepilone (Ixempra)

    Chemotherapy

  • 8/14/2019 Oncologic Nursing Part 2

    96/111

    Chemotherapy

    Agents While many of the commonly used chemotherapyagents fit into one of the three previously describedgroupings (Genotoxic, Cytoskeletal, and Anti-metabolite), some of them work through mechanisms

    that do not neatly fit into one of these categories. Arsenic trioxide (Trisenox) Bleomycin

    Hydroxyurea Streptozocin

    Chemotherapeutic

  • 8/14/2019 Oncologic Nursing Part 2

    97/111

    pAdministration

    Oral

    IM/ SQ

    IV

    Central Venous Catheter

    Venous Access Devices (VAD)

    Intraarterial Route Intraperitoneal Route

    STEM CELLS

  • 8/14/2019 Oncologic Nursing Part 2

    98/111

    STEM CELLS Stem cells are able to

    grow into other blood cells

    that mature and function

    as needed in the body.

    Stem cells create the

    three main types of blood

    cells:

    red blood cells

    white blood cells

    platelets

    tem ce s

  • 8/14/2019 Oncologic Nursing Part 2

    99/111

    e ce sLocation

    Bone marrow (the spongy center of thebone where blood cells are made)

    Peripheral blood (found in blood vesselsthroughout the body)

    Cord blood (found in the umbilical cordand collected after a babys birth)

    Stem cells for transplantation are obtained from any of these threeplaces.

    Transplant in

  • 8/14/2019 Oncologic Nursing Part 2

    100/111

    pCancer

    A. Stem Cell Transplant a procedure that is used

    in conjunction with high-

    dose chemotherapymore effective than

    conventionalchemotherapy indestroying myeloma cells

    restore blood cellproduction

    Types of Stem Celll

  • 8/14/2019 Oncologic Nursing Part 2

    101/111

    ypTransplants

    Bone marrow transplant stem cell-containing bone marrow is collected, stored,

    and infused following high-dose chemotherapy and/orradiation therapy.

    Peripheral blood stem cell (PBSC) transplant Procedure in which blood containing mobilized stem cells

    is collected by apheresis, stored, and infused followinghigh-dose chemotherapy and/or radiation therapy.

    Cord blood transplantsrefer to transplants where thestem cells are obtained from umbilical cord bld

    Transplants

  • 8/14/2019 Oncologic Nursing Part 2

    102/111

    Autologous transplants, patients receivetheir own stem cells.

    Syngeneic transplants, patients receive stem

    cells from their identical twin.Allogeneic transplants, patients receive stem

    cells from their brother, sister, or

    parent. A person who is not related to thepatient (an unrelated donor) also may beused.

    Transplants

    according to Donor

    THE CANCER PAIN

    http://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=ahttp://www.cancer.gov/dictionary/db_alpha.aspx?expand=a
  • 8/14/2019 Oncologic Nursing Part 2

    103/111

    PROBLEM

    PAINIn cancer is the most fearedand distressing symptom

    of the disease.

    THE CANCER PAINPROBLEM

  • 8/14/2019 Oncologic Nursing Part 2

    104/111

    WHO reveals that everyday at least 4million people suffer from cancer pain.

    30 50% of cancer patients undergoingtreatment, and up to 95% of patients withadvanced disease, suffer from pain.

    More than 50% of patients still sufferedfrom unrelieved cancer pain.

    PROBLEM

    WHO: 3 Step Analgesic LadderF C P i M t

  • 8/14/2019 Oncologic Nursing Part 2

    105/111

    For Cancer Pain Management

    Basic Principles:

    BY THE MOUTH

    If the patient can swallow, oral

    administration is the route of choice.

    WHO: 3 Step Analgesic LadderF C P i M t

  • 8/14/2019 Oncologic Nursing Part 2

    106/111

    BY THE CLOCK

    Analgesics should be given regularly andprophylactically.

    BY THE LADDERUse a few drugs well than many badly.

    For Cancer Pain Management

    WHO Three-Step

  • 8/14/2019 Oncologic Nursing Part 2

    107/111

    Analgesic Ladder Step IFor mild to moderate pain non-opioids

    (treatment of choice). may or may not be combinedwith adjuvant drugs (drugs that are used to hastenor add to the primary mode of treatment).

    Step II For moderate pain, who did not feel reliefafter using only non-opioids, a combination of opioidsand non-opioids should be tried. Again, adjuvants mayor may not be used.

    Step IIIFor moderate to severe pain, opioids shouldbe used, with or without non-opioids, and with orwithout adjuvants.

    WHO Three-StepA l i L dd

  • 8/14/2019 Oncologic Nursing Part 2

    108/111

    Analgesic Ladder

    ancer :

  • 8/14/2019 Oncologic Nursing Part 2

    109/111

    ManagementC ComfortA- Altered Body Image

    N NutritionC ChemotherapyE- Evaluate the Response in

    TreatmentR - Rest

    SUMMARY

  • 8/14/2019 Oncologic Nursing Part 2

    110/111

    SUMMARY Early detection and screening of high risk

    individuals play significant roles intreating cancer.

    Patient and family caregivers should beinvolved in all aspects of nursing care.

    Various treatment modalities are availableto cure, control and palliate cancer.

    SUMMARY

  • 8/14/2019 Oncologic Nursing Part 2

    111/111

    Safety Standards of treatment mustalways implemented.

    Life long surveillance for recurrence aftertreatment.

    SUMMARY